Aylward B (2014) Quote provided via personal communication with the authors, March 10.Google Scholar
Chan M (2007) Urgent stakeholder consultation on interrupting wild poliovirus transmission. Accessed January 4, 2014, http://www.who.int/dg/speeches/2007/280207_polio/en/.Google Scholar
Decade of Vaccines Collaboration (2013) Global vaccines action plan 2011–2020. Accessed January 4, 2014, http://issuu.com/decadeofvaccines/docs/globalvaccineactionplan/1?e=7336822/1584382.Google Scholar
de Gourville E, Duintjer Tebbens RJ, Sangrujee N, Pallansch MA, Thompson KM (2006) Global surveillance and the value of information: The case of the global polio laboratory network. Risk Anal. 26(6):1557–1569.Crossref, Google Scholar
Duintjer Tebbens RJ, Thompson KM (2009) Priority shifting and the dynamics of managing eradicable infectious diseases. Management Sci. 55(4):650–663.Link, Google Scholar
Duintjer Tebbens RJ, Thompson KM (2014) Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. J. Infectious Diseases 210(S1):S485–S497.Crossref, Google Scholar
Duintjer Tebbens RJ, Sangrujee N, Thompson KM (2006a) The costs of future polio risk management policies. Risk Anal. 26(6): 1507–1531.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Alexander JP, Thompson KM (2010) Optimal vaccine stockpile design for an eradicated disease: Application to polio. Vaccine 28(26):4312–4327.Crossref, Google Scholar
Duintjer Tebbens RJ, Kalkowska DA, Wassilak SGF, Pallansch MA, Cochi SL, Thompson KM (2014) The potential impact of expanding target age groups for polio immunization campaigns. BMC Infectious Diseases 14:45.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SG, Cochi SL, Thompson KM (2013) Characterizing poliovirus transmission and evolution: Insights from modeling experiences with polioviruses. Risk Anal. 33(4):703–749.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Kew OM, Cáceres VM, Sutter RW, Thompson KM (2005) A dynamic model of poliomyelitis outbreaks: Learning from the past to help inform the future. Amer. J. Epidemiology 162(4):358–372.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SGF, Linkins J, Sutter RW, Aylward RB, Thompson KM (2011) Economic analysis of the global polio eradication initiative. Vaccine 29(2):334–343.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Kew OM, Cáceres VM, Jafari H, Cochi SL, Sutter RW, Aylward RB, Thompson KM (2006b) Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 26(6):1471–1505.Crossref, Google Scholar
Duintjer Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkin M, Gary Het al. (2008) Uncertainty and sensitivity analyses of a decision analytic model for post-eradication polio risk management. Risk Anal. 28(4):855–876.Google Scholar
Edmunds J, Medley GF, Nokes DJ (1999) Evaluating the cost-effectiveness of vaccination programmes: A dynamic perspective. Statist. Medicine 18(23):3263–82.Crossref, Google Scholar
Gates B (2011) Annual letter 2011. Accessed January 4, 2014, http://www.gatesfoundation.org/who-we-are/resources-and-media/annual-letters-list/annual-letter-2011.Google Scholar
GAVI Alliance (2014) International Finance Facility for Immunisation (IFFIm) Polio eradication campaign: IFFIm helps lead the fight to eradicate polio. Accessed January 4, 2014, http://www.iffim.org/funding-gavi/results/polio-eradication-campaign/.Google Scholar
Hopkins JW (1989) The Eradication of Smallpox: Organizational Learning and Innovation in International Health (Westview Press, Boulder, CO).Google Scholar
Kalkowska DA, Duintjer Tebbens RJ, Thompson KM (2014a) Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India. J. Infectious Diseases 210(S1):S398–S411.Crossref, Google Scholar
Kalkowska DA, Duintjer Tebbens RJ, Thompson KM (2014b) Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria. J. Infectious Diseases 210(S1):S412–S423.Crossref, Google Scholar
Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296(5566):356–359.Crossref, Google Scholar
McKenna M (2008) Coalition declares “final push” to end polio. Accessed January 4, 2014, http://www.cidrap.umn.edu/cidrap/content/other/news/jun1808polio.html.Google Scholar
McKinlay MA, Collette MS, Hincks JR, Oberste MS, Pallansch MA, Okayasu H, Sutter RWet al. (2014) Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication. J. Infectious Diseases 210(S1):S447–S453.Crossref, Google Scholar
National Research Council (2006) Exploring the Role of antiviral drugs in the eradication of polio. Report, The National Academies Press, Washington, DC.Google Scholar
Oshinsky DM (2005) Polio: An American Story (Oxford University Press, Oxford, UK).Google Scholar
Pandak C (2014) Quote provided via personal communication with the authors, February 17.Google Scholar
Roberts L (2007) Polio: No cheap way out. Science 316(5823): 362–363.Crossref, Google Scholar
Rotary International (2013) Global vaccine summit yields US$4 billion in funding commitments to polio endgame plan. Accessed January 4, 2014, http://www.rotary.org/en/global-vaccine-summit-yields-us4-billion-funding-commitments-polio-endgame-plan.Google Scholar
Royston G (2011) Meeting global health challenges through operational research and management science. Bull. World Health Organ. 89(9):683–688.Crossref, Google Scholar
Sangrujee NK, Duintjer Tebbens RJ, Cáceres VM, Thompson KM (2003) Policy decision options during the first 5 years following certification of polio eradication. Accessed January 4, 2014, http://www.medscape.com/viewarticle/464841_3.Google Scholar
Thompson KM (2013) Modeling poliovirus risks and the legacy of polio eradication. Risk Anal. 33(4):505–515.Crossref, Google Scholar
Thompson KM (2014) Polio endgame management: Focusing on performance with or without inactivated poliovirus vaccine. Lancet 384(9953):1480–1482.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ (2006) Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal. 26(6):1423–1440.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ (2007) Eradication versus control for poliomyelitis: An economic analysis. Lancet 369(9570): 1363–1371.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ (2008a) The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation. Accessed January 4, 2014, http://www.medscape.com/viewarticle/578396.Google Scholar
Thompson KM, Duintjer Tebbens RJ (2008b) Using system dynamics to develop policies that matter: Global management of poliomyelitis and beyond. System Dynam. Rev. 24(4):433–449.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ (2014) Modeling the dynamics of oral poliovirus vaccine cessation. J. Infectious Diseases 210(S1):S475–S484.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ, Pallansch MA (2006a) Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal. 26(6):1541–1556.Crossref, Google Scholar
Thompson KM, Pallansch MA, Tebbens RJ, Wassilak SG, Cochi SL (2013a) Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal. 33(4): 647–663.Crossref, Google Scholar
Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SG, Kim JH, Cochi SL (2013b) Preeradication national vaccine policy options for poliovirus infection and disease control. Risk Anal. 33(4):516–543.Crossref, Google Scholar
Thompson KM, Duintjer Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkins M (2006b) Development and consideration of global policies for managing the future risks of poliovirus outbreaks: Insights and lessons learned through modeling. Risk Anal. 26(6):1571–1580.Crossref, Google Scholar
Thompson KM, Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkins Met al. (2008) The risks, costs, and benefits of future global policies for managing polioviruses. Amer. J. Public Health 98(7):1322–1330.Crossref, Google Scholar
World Health Assembly (1988) WHA41.28: Global eradication of poliomyelitis by the year 2000. Accessed January 4, 2014, http://www.who.int/ihr/polioresolution4128en.pdf.Google Scholar
World Health Assembly (2006) WHA59.1: Eradication of poliomyelitis. Accessed January 4, 2014, http://www.polioeradication.org/Portals/0/Document/Resources/WHA59_1_Eradication_poliomyelitis.pdf.Google Scholar
World Health Assembly (2008) WHA61.1: Poliomyelitis: Mechanism for management of potential risks to eradication. Accessed July 16, 2014, http://www.polioeradication.org/content/general/WHA61_Resolution_English.pdf.Google Scholar
World Health Organization (2001) Transmission of wild poliovirus type 2—apparent global interruption. Weekly Epidemiological Record 76:95–97.Google Scholar
World Health Organization (2005) Polio outbreak response: the faster, the better. Accessed January 4, 2014, http://www.polioeradication.org/content/polionews/polionews25.pdf.Google Scholar
World Health Organization (2007) Polio global eradication initiative May 2007. Accessed January 4, 2014, http://www.polioeradication.org/Mediaroom/Monthlysituationreports/2007/May.aspx.Google Scholar
World Health Organization (2010a) Enhancing global poliovirus surveillance and outbreak response. Accessed January 4, 2014, http://www.polioeradication.org/Portals/0/Document/Media/FactSheet/ EnhancingSurveillanceandOutbreakResponse.pdf.Google Scholar
World Health Organization (2010b) Economic benefits of the Global Polio Eradication Initiative estimated at US$40–50. Accessed January 4, 2014, http://www.polioeradication.org/tabid/167/iid/82/Default.aspx.Google Scholar
World Health Organization (2013) Economic case for polio eradication. Accessed January 4, 2014, http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EconomicCase.pdf.Google Scholar
World Health Organization (2014) Polio-free certification: WHO South-East Asia. Accessed January 4, 2014, http://www.searo.who.int/entity/immunization/topics/polio/eradication/sea-polio-free/en/.Google Scholar

Volume 45, Issue 1

2014 Franz Edelman Award for Achievement in Operations Research and the Management Sciences

January-February 2015

Pages 1-116

Article Information

Supplemental Material

Metrics

Information

Published Online:February 03, 2015

Cite as

Kimberly M. Thompson, Radboud J. Duintjer Tebbens, Mark A. Pallansch, Steven G.F. Wassilak, Stephen L. Cochi (2015) Polio Eradicators Use Integrated Analytical Models to Make Better Decisions. Interfaces 45(1):5-25.

https://doi.org/10.1287/inte.2014.0769

Keywords

Acknowledgments

We thank Dr. Bruce Aylward for providing the video recorded quotes about the impacts of our work, which we used in the Edelman Award presentations, and Drs. Aylward, Carol Pandak, and Walter Orenstein for providing stakeholder perspectives in discussions with the Edelman judges. We thank Katerina Alves, Sona Bari, Thomas Bell, Christopher Black, Ivana Boko, Lee Bookman, Louis Boviero, James Cosgrove, Christine Fares, Christine Feig, Jean-Marc Glinz, Brian Hirten, Alan Janssen, Todd Jordan, Sarah Poser, Oliver Rosenbauer, Bryon Skinner, and Jeanette St. Pierre for their help with preparing the audiovisual materials for our presentation, and the GPEI partners for the images used. We thank Sid Hess, Pelin Pekgun, Carrie Beam, and all of the Edelman judges and editors for providing comments. The first two authors acknowledge support for this article from CDC Cooperative Agreement [U66 IP000169]. The collaborative work described in this piece includes research performed with financial support for Kid Risk, Inc. and research in the form of grants and contracts from the U.S. Centers for Disease Control and Prevention (CDC) [Grants U50/CCU300860, U01 IP000029, NVPO N37 (FY2005) 200-2010-M-33379, 200-2010-M-33679, 200-2010-M-35172, and U66 IP000169]; the World Health Organization (WHO) [APW200179134]; the Bill & Melinda Gates Foundation [4533-17492, 4533-18487, 4533-21031, 4533-23446]; and unrestricted gifts to the Harvard Kids Risk Project. Finally, we thank collaborators from Kid Risk, Inc., including Dominika Kalkowska, Jong-Hoon Kim, and Kasper Kisjes; from CDC, including James Alexander, Lorraine Alexander, Larry Anderson, Gregory Armstrong, Albert Barskey, Carla Boudreau, Brenton Burkholder, Cara Burns, Victor Cáceres, Jason Cecil, Susan Chu, Paul Chenoweth, Kathleen Gallagher, Howard Gary, John Glasser, Steve Hadler, Karen Hennessey, Hamid Jafari, Julie Jenks, Denise Johnson, Bob Keegan, Olen Kew, Nino Khetsuriani, Robb Linkins, Benjamin Lopman, Naile Malakmadze, Rebecca Martin, Eric Mast, Steve McLaughlin, Steve Oberste, Patrick O’Connor, Becky Prevots, Hardeep Sandhu, Nalinee Sangrujee, Anne Schuchat, Jean Smith, Philip Smith, Peter Strebel, Linda Venczel, Gregory Wallace, Margie Watkins, and Bruce Weniger; and from the WHO, including (in addition to those mentioned previously) Fred Caillette, Claire Chauvin, Philippe Duclos, Esther de Gourville, Hans Everts, Marta Gacic-Dobo, Tracey Goodman, Ulla Griffiths, David Heymann, Scott Lambert, Asta Lim, Jennifer Linkins, Patrick Lydon, Chris Maher, Linda Muller, Roland Sutter, Rudi Tangermann, Chris Wolff, and David Wood. We also thank the Global Polio Laboratory Network, Harrie van der Avoort, Francois Bompart, Anthony Burton, Konstantin Chumakov, Laurent Coudeville, Walter Dowdle, Paul Fine, Michael Galway, Shanelle Hall, Neal Halsey, Tapani Hovi, Kun Hu, Jacob John, Samuel Katz, Tracy Lieu, Marc Lipsitch, Anton van Loon, Apoorva Mallya, Elizabeth Miller, Phil Minor, John Modlin, Van Hung Nguyen, Peter Patriarca, Christina Pedreira, Stanley Plotkin, Hazhir Rahmandad, Robert Scott, John Sever, Thomas Sorensen, John Sterman, Robert Weibel, Jay Wenger, and Peter Wright.

PDF download

Available Issues

Available Issues

Available Issues

Available Issues

Available Issues

Available Issues

Available Issues

Polio Eradicators Use Integrated Analytical Models to Make Better Decisions

References

Volume 45, Issue 1

Article Information

Supplemental Material

Metrics

Information

Cite as

Keywords

Sign Up for INFORMS Publications Updates and News